These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2013615

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient.
    Kubota R, Soldan SS, Martin R, Jacobson S.
    J Neurovirol; 2002 Feb; 8(1):53-7. PubMed ID: 11847592
    [Abstract] [Full Text] [Related]

  • 23. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.
    Kira J, Nakamura M, Sawada T, Koyanagi Y, Ohori N, Itoyama Y, Yamamoto N, Sakaki Y, Goto I.
    J Neurol Sci; 1992 Jan; 107(1):98-104. PubMed ID: 1578240
    [Abstract] [Full Text] [Related]

  • 24. Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM/TSP patients and HTLV-I carriers.
    Mukae H, Kohno S, Morikawa N, Kadota J, Matsukura S, Hara K.
    Microbiol Immunol; 1994 Jan; 38(1):55-62. PubMed ID: 8052162
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Plasmatic proinflammatory chemokines levels are tricky markers to monitoring HTLV-1 carriers.
    Chaves DG, Sales CC, de Cássia Gonçalves P, da Silva-Malta MC, Romanelli LC, Ribas JG, de Freitas Carneiro-Proietti AB, Martins ML.
    J Med Virol; 2016 Aug; 88(8):1438-47. PubMed ID: 26800845
    [Abstract] [Full Text] [Related]

  • 29. Cell surface phenotype and human T lymphotropic virus type 1 antigen expression in 12 T cell lines derived from peripheral blood and cerebrospinal fluid of West Indian, Guyanese and African patients with tropical spastic paraparesis.
    Gessain A, Saal F, Giron ML, Lasneret J, Lagaye S, Gout O, De Thé G, Sigaux F, Peries J.
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():333-41. PubMed ID: 2307964
    [Abstract] [Full Text] [Related]

  • 30. Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals.
    Saito M, Usuku K, Nobuhara Y, Matsumoto W, Kodama D, Sabouri AH, Izumo S, Arimura K, Osame M.
    J Neurol Sci; 2004 Apr 15; 219(1-2):157-61. PubMed ID: 15050452
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Fukushima N, Nishiura Y, Nakamura T, Kohno S, Eguchi K.
    Intern Med; 2007 Apr 15; 46(7):347-51. PubMed ID: 17409595
    [Abstract] [Full Text] [Related]

  • 33. An inverse correlation of HTLV-I viral load in CSF and intrathecal synthesis of HTLV-I antibodies in TSP/HAM.
    Puccioni-Sohler M, Rios M, Bianco C, Zhu SW, Oliveira C, Novis SA, Pombo-de-Oliveira MS.
    Neurology; 1999 Oct 12; 53(6):1335-9. PubMed ID: 10522895
    [Abstract] [Full Text] [Related]

  • 34. Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy.
    Umehara F, Nose H, Saito M, Fukuda M, Ogino M, Toyota T, Yuhi T, Arimura K, Osame M.
    J Neurovirol; 2007 Jun 12; 13(3):260-7. PubMed ID: 17613716
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis.
    Dekaban GA, King EE, Arp J, Palker TJ, Rice GP.
    Scand J Immunol; 1994 Aug 12; 40(2):171-80. PubMed ID: 8047838
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Local and systemic production of proinflammatory chemokines in the pathogenesis of HAM/TSP.
    Guerra M, Luna T, Souza A, Amorim C, Carvalho NB, Carvalho L, Tanajura D, Cardoso LS, Carvalho EM, Santos S.
    Cell Immunol; 2018 Dec 12; 334():70-77. PubMed ID: 30473006
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.